Fig. 4From: 2024 UPDATE: the Brazilian Diabetes Society position on the management of metabolic dysfunction-associated steatotic liver disease (MASLD) in people with prediabetes or type 2 diabetesScreening and management of MASLD in patients with prediabetes or type 2 diabetes. *Depending on availability. **Drugs with proven benefits in MASLD. ***See Table 1Back to article page